Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CEST

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
04/23MERCK : Life Science Business of Merck KGaA, Darmstadt, Germany Receives Patent ..
PU
04/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
04/23MERCK KGAA : Darmstadt, Germany, Presents New Osteoarthritis Data at OARSI 2018 ..
AQ
04/23P&G Acquires the Consumer Health Business of Merck KGaA, Darmstadt, Germany
AQ
04/21PROCTER & GAMBLE : P&G Acquires the Consumer Health Business of Merck KGaA, Darm..
AQ
04/20P&G's vitamin boost could signal more to come
RE
04/20P&G to buy majority stake in Merck India business for Rs1,300 crore
AQ
04/20Corrections & Amplifications -- WSJ
DJ
04/19MERCK : New Science Data Have Been Reported by Researchers at Merck KGaA (Curiou..
AQ
04/19MERCK : Darmstadt, Germany, University of Cape Town and Medicines for Malaria Ve..
PU
More news
News from SeekingAlpha
04/20Key events next week - healthcare 
04/19Merck's (MKGAF) CEO Stefan Oschmann on Procter & Gamble To Acquire Consumer H.. 
04/19Merck KGaA 2018 Q1 - Results - Earnings Call Slides 
04/19Procter & Gamble (PG) To Acquire Consumer Health Business Of Merck KGaA - Sli.. 
04/13Mylan aiming for Merck KGaA's consumer unit 
Financials (€)
Sales 2018 15 226 M
EBIT 2018 2 909 M
Net income 2018 1 702 M
Debt 2018 8 289 M
Yield 2018 1,56%
P/E ratio 2018 20,01
P/E ratio 2019 18,15
EV / Sales 2018 1,24x
EV / Sales 2019 1,09x
Capitalization 10 634 M
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 98,1 €
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-9.33%12 989
ABBVIE-5.53%147 832
KYOWA HAKKO KIRIN CO LTD6.53%12 506
JAZZ PHARMACEUTICALS PLC14.75%9 308
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD39.29%8 424
CONVATEC GROUP4.09%5 863